US Physical Therapy Q4 2023 Adj EPS $0.59 Beats $0.57 Estimate, Sales $154.80M Beat $150.27M Estimate
Portfolio Pulse from Benzinga Newsdesk
US Physical Therapy (USPH) reported Q4 2023 adjusted EPS of $0.59, surpassing the $0.57 estimate, and sales of $154.80M, exceeding the $150.27M estimate. This represents a 1.72% increase in EPS and a 9.65% increase in sales from the same period last year.
February 28, 2024 | 10:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
US Physical Therapy reported a positive earnings surprise for Q4 2023, with both EPS and sales exceeding analyst estimates, indicating strong financial performance.
US Physical Therapy's Q4 2023 earnings report exceeded analyst expectations in both EPS and sales, demonstrating a solid financial performance and growth compared to the same period last year. This positive earnings surprise is likely to instill investor confidence and could lead to a short-term uptick in USPH's stock price, as markets typically react favorably to earnings beats.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100